Corrigendum to “Disease-free Survival Analysis for Patients with High-risk Muscle-invasive Urothelial Carcinoma from the Randomized CheckMate 274 Trial by PD-L1 Combined Positive Score and Tumor Cell Score” [Eur. Urol. 83(5) (2024) 432–440],European Urology

当前位置： X-MOL 学术 › Eur. Urol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Corrigendum to “Disease-free Survival Analysis for Patients with High-risk Muscle-invasive Urothelial Carcinoma from the Randomized CheckMate 274 Trial by PD-L1 Combined Positive Score and Tumor Cell Score” [Eur. Urol. 83(5) (2024) 432–440]
European Urology ( IF 23.4 ) Pub Date : 2024-01-03 , DOI: 10.1016/j.eururo.2023.12.013
Matthew D. Galsky , Dean F. Bajorin , Johannes Alfred Witjes , Jürgen E. Gschwend , Yoshihiko Tomita , Federico Nasroulah , Jun Li , Sandra Collette , Begoña P. Valderrama , Marc-Oliver Grimm , Leonard Appleman , Gwenaelle Gravis , Andrea Necchi , Dingwei Ye , Frank Stenner , Megan Wind-Rotolo , Joshua Zhang , Keziban Ünsal-Kaçmaz

Abstract not available

中文翻译：